small molecule

ELURYNG

ETHINYL ESTRADIOL; ETONOGESTREL

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameELURYNG
Active ingredientETHINYL ESTRADIOL; ETONOGESTREL
Strength0.015MG/24HR;0.12MG/24HR
Dosage formRING
RouteVAGINAL
ModalitySmall molecule
FDA approvalDecember 2019
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.